Real-time enrollment status for this intermittent explosive disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:47 AM UTC
| NCT Number | NCT06118567 |
| Recruiting Status | Recruiting |
| Condition | Intermittent Explosive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University |
| Last Updated on CT.gov | March 27, 2025 (Mar 27, 2025) |
As of July 17, 2026: Clinical trial NCT06118567 is currently recruiting participants. This phase2 study for intermittent explosive disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06118567 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06118567 was last updated Mar 27, 2025 (March 27, 2025). HelloStudys verifies this status automatically.